DK108281C - Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf. - Google Patents

Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf.

Info

Publication number
DK108281C
DK108281C DK115064AA DK115064A DK108281C DK 108281 C DK108281 C DK 108281C DK 115064A A DK115064A A DK 115064AA DK 115064 A DK115064 A DK 115064A DK 108281 C DK108281 C DK 108281C
Authority
DK
Denmark
Prior art keywords
esters
preparation
dihydroxy steroids
steroids
dihydroxy
Prior art date
Application number
DK115064AA
Other languages
Danish (da)
English (en)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of DK108281C publication Critical patent/DK108281C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK115064AA 1959-10-12 1960-10-11 Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf. DK108281C (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84559559A 1959-10-12 1959-10-12
US84559459A 1959-10-12 1959-10-12
US84566159A 1959-10-12 1959-10-12

Publications (1)

Publication Number Publication Date
DK108281C true DK108281C (da) 1967-11-06

Family

ID=27420319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115064AA DK108281C (da) 1959-10-12 1960-10-11 Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf.

Country Status (7)

Country Link
BE (1) BE595971A (instruction)
CH (1) CH392500A (instruction)
DE (1) DE1188079B (instruction)
DK (1) DK108281C (instruction)
FR (2) FR1428454A (instruction)
GB (2) GB959378A (instruction)
NL (1) NL6810178A (instruction)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069322A (en) * 1976-10-12 1978-01-17 Interx Research Corporation Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
HUE027463T2 (en) 2008-05-28 2016-09-28 Reveragen Biopharma Inc Non-hormonal steroid modulators of nf-kb for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2866799A (en) * 1957-01-02 1958-12-30 Merck & Co Inc Method for converting a 17-20, 20-21 bismethylenedioxy or a 17-20, 20-21 bis-substituted methylenedioxy steroid of the pregnane series to a 17alpha, 21-dihydroxy-20-ketosteroid of the pregnane series

Also Published As

Publication number Publication date
BE595971A (fr) 1961-02-01
GB959378A (en) 1964-06-03
CH392500A (de) 1965-05-31
GB959377A (en) 1964-06-03
NL6810178A (instruction) 1968-10-25
DE1188079B (de) 1965-03-04
FR957M (instruction) 1961-11-27
FR1428454A (fr) 1966-02-18

Similar Documents

Publication Publication Date Title
DK103510C (da) Fremgangsmåde til fremstilling af 3-oxo-Δ<1>-10α-methylsteroider af androstanrækken eller af pregnanrækken.
DK108281C (da) Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf.
DK105020C (da) Fremgangsmåde til fremstilling af 21-dihydrogenphosphater af 16α,17α-acetaler eller -ketaler af 6-halogen-4-pregnen-16α,17α,21-triol-3,20-dioner eller alkalimetalsalte heraf.
DK118874B (da) Fremgangsmåde til fremstilling af 9α,11β-dihalogensteroider af pregnan- eller androstanrækken.
DK105528C (da) Fremgangsmåde til fremstilling af 6α,16α-dimethyl-11-oxygeneret-1,4-pregnadien-17α,21-diol-3,20-dionforbindelser.
DK119556B (da) Fremgangsmåde til fremstilling af 9α-fluor-16β-methyl-derivater af hydrocortison eller prednisolon eller 21-acetater deraf.
DK108860C (da) Fremgangsmåde til fremstilling af 11-oxygenerede 6α-fluor-9α-halogen-16β-methyl-1,4-pregnadien-17α,21-diol-3,20-dioner eller 21-estere deraf.
DK119156B (da) Fremgangsmåde til fremstilling af 6α-methyl-16-methylen-steroider af pregnanrækken.
DK98178C (da) Fremgangsmåde til fremstilling af 9α-fluor-16-methylen-1,4-pregnadien-11β,17α,21-triol-3,20-dion eller 21-estere deraf.
DK105019C (da) Fremgangsmåde til fremstilling af 6α-chlor- eller 6α-brom-9α-flour-16α-methyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner eller estere heraf.
DK98495C (da) Fremgangsmåde til fremstilling af 16α,17α-acetaler eller -ketaler af 6-halogen-4-pregnen-16α,17α-diol-3,20-dion.
DK95172C (da) Fremgangsmåde til fremstilling af 2-alkyl-11β,17α,21-trihydroxy-4-pregnen-3,20-dioner eller 21-estere heraf.
DK100813C (da) Fremgangsmåde til fremstilling af Δ<4,6>-eller Δ<1,4,6>-3-keto-6-halogensteroider af androstan- eller pregnanrækken.
DK106608C (da) Fremgangsmåde til fremstilling af 16α-chlormethyl-Δ<1,4>-pregnadien- 11β,21-diol-3,20-dion eller 21-estere deraf.
DK94891C (da) Fremgangsmåde til fremstilling af 21-hydroxy-A-nor-progesteron eller 21-estere deraf.
DK98002C (da) Fremgangsmåde til fremstilling af 11β,17α,21-trihydroxy-16α-methyl-4-pregnen-3,20-dion.
DK107290C (da) Fremgangsmåde til fremstilling af 16-methylen-steroider.
DK97940C (da) Fremgangsmåde til fremstilling af 16-halogenmethylen-1,4-pregnadienforbindelser eller 21-estere deraf.
DK128606B (da) Fremgangsmåde til fremstilling af 16β-metylprednison eller 21-acetatet deraf.
DK118556B (da) Analogifremgangsmåde til fremstilling af 16α-methyl-9α-chlor-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner eller 21-estere deraf.
DK89681C (da) Fremgangsmåde til fremstilling af 16α,21-dialkanoyloxy-17α-hydroxy-9β,11β-oxido-1,4-pregnadien-3,20-dioner.
DK89185C (da) Fremgangsmåde til fremstilling af 17α,21-dihydroxy-20-keto-steroider af pregnanrækken.
DK99745C (da) Fremgangsmåde til fremstilling af 11β,17α,21-trihydroxy-6α,16α-dimethyl-4-pregnen- eller -1,4-pregnadien-3,20-dion.
DK95318C (da) Fremgangsmåde til fremstilling af 17α-acyloksy-6-metyl-16-metylen-4,6-pregnadien-3,20-dioner.
DK93348C (da) Fremgangsmåde til fremstilling af 6-methyl-17α-acyloxy-4,6-pregnadien-3,20-dioner.